GlassScriptPhysician profile
Esteban Calderon
NPI 1144740838
$8,571.91
in general payments reported to CMS, 2019-2025
9 companies · $7,879 in 2025
The $7,879 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.46 · 2023: $469 · 2024: $212 · 2025: $7,879.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $3,308 · Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $3,308.19 |
| Food and Beverage | $751.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,220.48 | 2022-2025 | |
| Transmedics, INC. | $2,628.64 | 2025 | Organ Care System |
| Organox LTD | $166.80 | 2023 | Metra |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $155.30 | 2023 | |
| Kerecis Limited | $147.10 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Dilon Technologies, INC. | $142.88 | 2024 | Hemoblast Bellows |
| Medtronic, INC. | $68.65 | 2024 | Signia |
| Ardelyx, INC. | $23.46 | 2025 | Ibsrela |
| Baxter Healthcare | $18.60 | 2025 | Preveleak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esteban Calderon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.